Clinical Trials Directory

Trials / Completed

CompletedNCT03330925

Safety and Feasibility of the ElastiMed's SACS

Safety and Feasibility of the ElastiMed's SACS - Smart Active Compression Stocking

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
ElastiMed ltd · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The main objective of this study is to demonstrate the safety and the feasibility of this device, and its ability to increase venous blood flow Primary safety Endpoint: To demonstrate the safety of the device- no serious adverse effect Primary feasibility Endpoint: Increase the blood flow velocity The blood flow will be detected by a Duplex Ultrasonography test at the popliteal vein and the femoral vein. The volunteers will rest at controlled environment room . Measurements will be performed after 30 min of rest without the device on the leg (baseline) and after 30 min of device activity .

Conditions

Interventions

TypeNameDescription
DEVICEElastiMed's SACSA wearable medical device that improve circulation using smart materials

Timeline

Start date
2018-01-24
Primary completion
2018-12-03
Completion
2018-12-03
First posted
2017-11-06
Last updated
2019-06-06

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03330925. Inclusion in this directory is not an endorsement.

Safety and Feasibility of the ElastiMed's SACS (NCT03330925) · Clinical Trials Directory